March 14 (Reuters) - Ipsen Sa IPN.PA
* Ipsen announces health canada approval of dysport therapeutic (abobotulinumtoxina) for the treatment of patients with cervical dystonia and adult upper limb spasticity Source text for Eikon: ID:nCNWCQB8Ra Further company coverage: IPN.PA